Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Tunneled central venous catheters in a gynecologic oncology service: operative and short-term complications
1Indiana Women’s Oncology, St. Vincent Hospitals, Indianapolis, IN, USA
2Division of Gynecologic Oncology, Holden Comprehensive Cancer Center, University of Iowa, IA City, USA
*Corresponding Author(s): J.P. Geisler E-mail: jgeisler@indianawomensoncology.com
Purpose: To determine the difference in the immediate complication rate between placement of long-term central venous catheters (LTCVCs) by the percutaneous versus jugular venous cutdown method. Method: Case lists were examined to determine the number of LTCVCs placed during the designated time period. Medical records, operative reports, and chest roentgenograms were examined to extract pertinent information. Immediate complications included complications occurring in the operating room until 30 days postoperatively. Complications included misplacement of the catheter requiring an adjustment or a repeat procedure, pneumothorax, hydrothorax, or hemothorax, operative site or tunnel infection, and line migration requiring removal. Results: Five hundred and one patients had LTCVCs placed during the period of this study. This included 399 totally implantable venous access devices (TIVADs) and 102 free access venous access devices (FAVADs) with 163 placed percutaneously into subclavian veins and 338 placed by cutdown into jugular veins. There was a significant increased risk in the overall immediate complication rate for the percutaneous placement compared to venous cutdown (p < 0.001). Also, pneumothorax was more common with the percutaneous approach compared to the venous cutdown approach (p < 0.001). Conclusions: Immediate complications, especially pneumothorax, were more common when placing catheters by the percutaneous approach as compared to the venous cutdown approach.
Implanted catheters; Central venous catheters; Gynecologic oncology, Percutaneous; Venous cutdown
J.P. Geisler,R.E. Buller,K.J. Manahan. Tunneled central venous catheters in a gynecologic oncology service: operative and short-term complications. European Journal of Gynaecological Oncology. 2008. 29(2);141-143.
[1] Roy R.B., Wilkinson R.H., Bayliss C.E.: “The utilization of long nylon catheters for prolonged intravenous infusions”. Can Med. Assoc. J., 1967, 96, 94.
[2] Cunningham M.J., Collins M.B., Kredenster D.C., Malfetano J.H.: “Peripheral infusion ports for central venouas access in patients with gynecologic malignancies”. Gynecol. Oncol., 1996, 60, 397.
[3] Oakley G.J., Downey G.O., King L.A., Carlson L.F., Twiggs L.B., Adcock L.L.: “Symptomatic central venous thrombosis and longterm right atrial catheters”. Gynecol. Oncol., 1990, 36, 459.
[4] Minassian V.A., Sood A.K., Lowe P., Sorosky J.I., Al-Jurf A.S., Buller R.E.: “Long-term central venous access in gynecologic cancer patients”. J. Am. Coll. Surg., 2000, 191, 403.
[5] Gleeson N.C., Fiorica J.V., Mark J.E., Pinelli D.M., Hoffman M.S., Roberts W.S., Cavanagh D.: “Externalized Groshong catheters and Hickman ports for centralized venous access in gynecologic oncology patients”. Gynecol. Oncol., 1993, 51, 372.
[6] Mirro J., Rao B.N., Kumar M., Rafferty M., Hancock M., Austin B.A. et al.: “A comparison of placement techniques and complications of externalized catheters and implantable ports use in children with cancer”. J. Pediatr. Surg., 1990, 25, 120.
[7] Trerotola S.O., Kuhn-Fulton J., Johnson M.S., Shah H., Ambrosius W.T., Kneebone P.H.: “Tunneled infusion catheters: increased incidence of symptomatic venous thrombosis after subclavian versus internal jugular access”. Radiology, 2000, 217, 89.
[8] McGee D.C., Gould M.K.: “Current concepts: preventing complications of central venous catheterization”. NEJM, 2003, 348, 1123.
[9] Reuber M., Dunkley L.A., Uron E.P., Bell M.D., Bamford J.M.: “Stroke after internal jugular venous cannulation”. Acta Neurol. Scand., 2002, 105, 235.
[10] Reddy G., Coombes A., Hubbard A.D.: “Horner’s syndrome following internal jugular cannulation”. Int. Care Med., 1998, 24, 194.
[11] Rauthe G., Altmann C.: “Complications in connection with venous port systems: pervention and therapy”. Eur. J. Surg. Oncol., 1998, 24, 192.
[12] McGee D.C., Gould M.K.: “Current concepts: preventing complications of central venous catheterization”. NEJM, 2003, 348, 1123.
[13] Nelson B.E., Mayer A.R., Tseng P.C., Schwartz P.E.: “Experience with the intravenous totally implanted port in patients with gynecologic malignancies”. Gynecol. Oncol., 1994, 53, 98.
[14] Ruesch S., Walder B., Tramer M.R.: “Complications of central venous catheters: internal jugular versus subclavian access - a systematic review”. Crit. Care Med., 2002, 30, 454.
[15] Di Carlo I., Cordio S., La Greca G., Privitera G., Russello D., Puleo S., Latteri F.: “Totally implantable venous access devices implanted surgically”. Arch. Surg., 2001, 136, 1050.
Top